Flt4 (VEGFR-3) as a target for tumor imaging and anti-tumor therapy

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8940695
SERIAL NO

11327075

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provide purified Flt4 receptor tyrosine kinase polypeptides and fragments thereof, polynucleotides encoding such polypeptides, antibodies that specifically bind such polypeptides, and uses therefor.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
OCELOT SPV LP38 JERMYN STREET LONDON SW1Y 6DN

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Alitalo, Kari Helsinki, FI 130 1966
Makinen, Taija Munich, DE 9 78

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jul 27, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00